Eleven Biotherapeutics

Eleven Biotherapeutics

Eleven Biotherapeutics

Eleven Biotherapeutics is focused on developing innovative protein-basedtherapeutics to improve human health and treat diseases.
Founded
2010
Raised
$63M
Follow us
Alexa global traffic share
Latest funding Show all
$8,000,000
Post-IPO equity - 2017
$20,000,000
Post-IPO equity - 2014
Team Size
10+
Employees
Acquisition
Seeking Alpha , businesswire

Eleven Biotherapeutics acquires Viventia Bio in all-stock deal